Samuele Ferrari

14PUBLICATIONS
88CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)HaematologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 16, 2026
VEXAS syndrome.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Apr 16, 2025
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

|Apr 08, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Raffaella Molteni, Martina Fiumara, Corrado Campochiaro

|Feb 07, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency.

Maria Carmina Castiello, Chiara Brandas, Samuele Ferrari

Pageof 3